Literature DB >> 25060825

Health-related quality of life 14 years after preoperative short-term radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomised trial.

Lisette M Wiltink1, Tina Y T Chen2, Remi A Nout1, Elma Meershoek-Klein Kranenbarg3, Marta Fiocco4, Søren Laurberg2, Cornelis J H van de Velde3, Corrie A M Marijnen5.   

Abstract

BACKGROUND: Preoperative short-term radiotherapy (PRT) in combination with total mesorectal excision (TME) has shown to improve local control in rectal cancer treatment, however without a survival benefit and at the cost of increased morbidity. The current study investigates the long-term health-related quality of life (HRQL) of patients 14 years after treatment in the Dutch TME trial.
METHODS: In the TME trial (1996-1999) 1530 Dutch patients with rectal cancer were treated with TME and randomly assigned to PRT (5 × 5 Gy). In 2012 HRQL was evaluated in surviving patients (n=606) using a questionnaire combining EORTC QLQ-C30, EORTC QLQ-CR29 and additional questions.
FINDINGS: Results were obtained from 478 patients (82%), with a median follow up of 14 years. PRT+TME patients without stoma reported more faecal leakage and higher stool frequency, resulting in increased need of pads. Furthermore, irradiated males reported more erection problems. However, radiotherapy did not have negative effects on overall functioning. Compared with Dutch population, patients in both treatment arms reported a small decrease in overall functioning and males reported less sexual activity, interest and enjoyment and more erection difficulties. Irradiated females reported more vaginal dryness and more pain at intercourse compared with Dutch population.
INTERPRETATION: Long-term HRQL evaluation shows that treatment-related symptoms are still present 14 years after treatment for rectal cancer. Radiotherapy increased bowel dysfunction in patients without stoma. Compared with the Dutch population, both groups reported increased sexual dysfunction. Despite these treatment-related symptoms, there was no difference in overall functioning and global health between TME and PRT+TME.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Mesorectal; Quality of life; Randomised trial; Rectal; Very long-term follow-up

Mesh:

Year:  2014        PMID: 25060825     DOI: 10.1016/j.ejca.2014.06.020

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  14 in total

1.  Tumor volume reduction rate is superior to RECIST for predicting the pathological response of rectal cancer treated with neoadjuvant chemoradiation: Results from a prospective study.

Authors:  Jian Xiao; Yuting Tan; Wenyun Li; Jiaying Gong; Zhiyang Zhou; Yan Huang; Jian Zheng; Yanhong Deng; Lei Wang; Junsheng Peng; Donglin Ren; Ping Lan; Jianping Wang
Journal:  Oncol Lett       Date:  2015-04-07       Impact factor: 2.967

2.  To what extent is the low anterior resection syndrome (LARS) associated with quality of life as measured using the EORTC C30 and CR38 quality of life questionnaires?

Authors:  Juliane Kupsch; Matthias Kuhn; Klaus E Matzel; Joerg Zimmer; Olga Radulova-Mauersberger; Anja Sims; Helmut Witzigmann; Sigmar Stelzner
Journal:  Int J Colorectal Dis       Date:  2019-02-05       Impact factor: 2.571

3.  [Role of neoadjuvant radiotherapy for rectal cancer : Is MRI-based selection a future model?].

Authors:  Y Kulu; T Hackert; J Debus; M-A Weber; M W Büchler; A Ulrich
Journal:  Chirurg       Date:  2016-07       Impact factor: 0.955

4.  Quality of Life After Radiotherapy for Rectal and Anal Cancer.

Authors:  Shane S Neibart; Sharon L Manne; Salma K Jabbour
Journal:  Curr Colorectal Cancer Rep       Date:  2020-01-16

Review 5.  Sexual Dysfunction in Ostomized Patients: A Systematized Review.

Authors:  Mª Teresa García-Rodríguez; Adriana Barreiro-Trillo; Rocío Seijo-Bestilleiro; Cristina González-Martin
Journal:  Healthcare (Basel)       Date:  2021-04-29

6.  Long-Term Quality of Life of Retroperitoneal Sarcoma Patients Treated with Pre-Operative Radiotherapy and Surgery.

Authors:  Philip Wong; Zahra Kassam; Amanda N Springer; Rebecca Gladdy; Peter Chung; Jolie Ringash; Charles Catton
Journal:  Cureus       Date:  2017-10-11

Review 7.  Controversial issues in radiotherapy for rectal cancer: a systematic review.

Authors:  Jong Hoon Kim
Journal:  Radiat Oncol J       Date:  2017-12-29

Review 8.  Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie?

Authors:  Mareike K Thompson; Philip Poortmans; Anthony J Chalmers; Corinne Faivre-Finn; Emma Hall; Robert A Huddart; Yolande Lievens; David Sebag-Montefiore; Charlotte E Coles
Journal:  Br J Cancer       Date:  2018-07-31       Impact factor: 7.640

Review 9.  Pelvic radiotherapy and sexual function in women.

Authors:  Pernille Tine Jensen; Ligita Paskeviciute Froeding
Journal:  Transl Androl Urol       Date:  2015-04

10.  Self-reported sexual dysfunction in patients with rectal cancer.

Authors:  M Sörensson; D Asplund; P Matthiessen; J Rosenberg; T Hallgren; C Rosander; E González; D Bock; E Angenete
Journal:  Colorectal Dis       Date:  2019-12-06       Impact factor: 3.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.